Header Logo

Connection

KEVIN GAREY to Chenodeoxycholic Acid

Back to Details
This is a "connection" page, showing publications KEVIN GAREY has written about Chenodeoxycholic Acid.
KEVIN GAREY
Connection Strength
0.245
Chenodeoxycholic Acid
  1. Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin. Antimicrob Agents Chemother. 2025 Feb 13; 69(2):e0125124.
    View in: PubMed
    Score: 0.245
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.